Recently I am researching about NATIONAL-CANCER-INSTITUTE; TYROSINE KINASE; DRUG DISCOVERY; HYBRID, Saw an article supported by the Baburaoji Gholap Research Center. Published in ACADEMIC PRESS INC ELSEVIER SCIENCE in SAN DIEGO ,Authors: Basal, NK; Sonawane, RB; Jagtap, SV. The CAS is 67-51-6. Through research, I have a further understanding and discovery of 3,5-Dimethyl-1H-pyrazole. Application In Synthesis of 3,5-Dimethyl-1H-pyrazole
A new series of 2,4-dimethyl-1H-pyrrole-3-carboxamide derivatives bearing benzimidazole moiety was synthesized through a molecular hybridization approach and evaluated for in vitro anticancer activity by NCI-60 on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate and breast cancer cell lines at a single dose (10 mu M). Among all the synthesized conjugates, some derivatives showed more or less good activity even at such a small dose, while, compound 5-(1H-benzo[d]imidazol-2-yl) N (1-cyclohexylethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (80 displayed significant antiproliferative activity specifically against MDA-MB human cancer cell lines. Compound 8f showed promising activity against MDA-MB-435 cell line of melanoma (Growth inhibition: 62.46%) and MDA-MB-468 cell line of breast (Growth inhibition: 40.24%). Computational ADME study qualified its significant physicochemical, pharmacokinetic and drug-likeness properties with good predicted oral bioavailability. Thus this new hybrid molecules would be useful for further anticancer drug development.
Welcome to talk about 67-51-6, If you have any questions, you can contact Basal, NK; Sonawane, RB; Jagtap, SV or send Email.. Application In Synthesis of 3,5-Dimethyl-1H-pyrazole
Reference:
Pyrazole – Wikipedia,
,Pyrazoles – an overview | ScienceDirect Topics